Page last updated: 2024-09-04
docetaxel anhydrous and calpeptin
docetaxel anhydrous has been researched along with calpeptin in 1 studies
Compound Research Comparison
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (calpeptin) | Trials (calpeptin) | Recent Studies (post-2010) (calpeptin) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 289 | 0 | 99 |
Protein Interaction Comparison
Protein | Taxonomy | docetaxel anhydrous (IC50) | calpeptin (IC50) |
---|---|---|---|
Calpain-9 | Homo sapiens (human) | 2.84 | |
Calpain-1 catalytic subunit | Homo sapiens (human) | 0.3472 | |
Procathepsin L | Homo sapiens (human) | 0.072 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 4.81 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 4.81 | |
Cathepsin K | Homo sapiens (human) | 0.0001 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Ansa-Addo, EA; Inal, J; Jorfi, S; Kholia, S; Lange, S; Stratton, D; Valley, S | 1 |
Other Studies
1 other study(ies) available for docetaxel anhydrous and calpeptin
Article | Year |
---|---|
Inhibition of microvesiculation sensitizes prostate cancer cells to chemotherapy and reduces docetaxel dose required to limit tumor growth in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Calpain; Cell Line, Tumor; Cell Proliferation; Cell-Derived Microparticles; Dipeptides; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Humans; Male; Mice; Mice, Nude; Prostatic Neoplasms; Taxoids; Treatment Outcome | 2015 |